The Destructive Alliance: Interactions Of Leukocytes, Cerebral Endothelial Cells, and the Immune Cascade in Pathogenesis of Multiple Sclerosis

International Review of Neurobiology

Volumn 79, Issue , 2007, Pages 1-11

  Minagar, Alireza ^a   Carpenter, April ^a   Alexander, J Steven ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; ENDOTHELIUM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; LEUKOCYTE; MULTIPLE SCLEROSIS; PATHOLOGY; REVIEW;

BRAIN; ENDOTHELIAL CELLS; HUMANS; IMMUNE SYSTEM; LEUKOCYTES; MULTIPLE SCLEROSIS;

EID: 34248663505     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)79001-3     Document Type: Review

References (53)

1. Abbott N.J., Ronnback L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006) 41-53
2. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann. Neurol. 55 (2004) 458-468
3. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., and Janeway Jr. C.A. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177 (1993) 57-68
4. Briskin M.J., McEvoy L.M., and Butcher E.C. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 363 6428 (1993) 461-464
5. Bruck W., Lucchinetti C., and Lassmann H. The pathology of primary progressive multiple sclerosis. Mult. Scler. 8 (2002) 93-97
6. Cross A.H., Cannella B., Brosnan C.F., and Raine C.S. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63 (1990) 162-170
7. Del Maschio A., De Luigi A., Martin-Padura I., Brockhaus M., Bartfai T., Fruscella P., Adorini L., Martino G., Furlan R., De Simoni M.G., and Dejana E. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 190 (1999) 1351-1356
8. Engelhardt B., Laschinger M., Schulz M., Samulowitz U., Vestweber D., and Hoch G. The development of experimental autoimmune encephalomyelitis in the mouse requires α4-integrin but not α4β7-integrin. J. Clin. Invest. 102 (1998) 2096-2105
9. Engelhardt B., Wolburg-Buchholz K., and Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc. Res. Tech. 52 (2001) 112-129
10. Engelhardt B., Kempe B., Merfeld-Clauss S., Laschinger M., Furie B., Wild M.K., and Vestweber D. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J. Immunol. 175 (2005) 1267-1275
11. Floris S., Ruuls S.R., Wierinckx A., van der Pol S.M., Dopp E., van der Meide P.H., Dijkstra C.D., and De Vries H.E. Interferon-beta directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 127 (2002) 69-79
12. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 354 (2006) 942-955
13. Ghosh S., Goldin E., Gordon F.H., Malchow H.A., Rask-Madsen J., Rutgeerts P., Vyhnalek P., Zadorova Z., Palmer T., Donoghue S., and Natalizumab Pan-European Study Group. Natalizumab for active Crohn's disease. N. Engl. J. Med. 348 (2003) 24-32
14. Graesser D., Solowiej A., Bruckner M., Osterweil E., Juedes A., David S., Ruddle N.H., Engelhardt B., and Madri J.A. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109 (2002) 383-392
15. Greenwood J., Howes R., and Lightman S. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage. Lab. Invest. 70 (1994) 39-52
16. Greenwood J., Wang Y., and Calder V.L. Lymphocyte adhesion and transendothelial migration in the central nervous system: The role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology 86 (1995) 408-415
17. Greenwood J., Amos C.L., Walters C.E., Courand P.O., Lyck R., Engelhardt B., and Adamson P. Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J. Immunol. 171 (2003) 2099-2108
18. Hatterer E., Davoust N., Didier-Bazes M., Vuaillat C., Malcus C., Belin M.F., and Nataf S. How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes. Blood 107 (2006) 806-812
19. Jimenez J., Jy W., Mauro L.M., Horstman L.L., Ahn E.R., Ahn Y.S., and Minagar A. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult. Scler. 11 (2005) 310-315
20. Jy W., Minagar A., Jimenez J.J., Sheremata W.A., Mauro L.M., Horstman L.L., Bidot C., and Ahn Y.S. Endothelial microparticles (EMP) bind and activate monocytes: Elevated EMP-monocyte conjugates in multiple sclerosis. Front. Biosci. 9 (2004) 3137-3144
21. Kanwar J.R., Kanwar R.K., Wang D., and Krissansen G.W. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression. Immunol. Cell Biol. 78 (2000) 641-645
22. Keegan B.M., and Noseworthy J.H. Multiple sclerosis. Annu. Rev. Med. 53 (2002) 285-302
23. Kort J.J., Kawamura K., Fugger L., Weissert R., and Forsthuber T.G. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J. Neuroimmunol. 173 (2006) 23-34
24. Kumpfel T., Heydari N., and Hohlfeld R. Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis. Nervenarzt 73 (2002) 552-555
25. Laschinger M., and Engelhardt B. Interaction of α4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 102 (2000) 32-43
26. Laschinger M., Vajkoczy P., and Engelhardt B. Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur. J. Immunol. 32 (2002) 3598-3606
27. Lossinsky A.S., Badmajew V., Robson J.A., Moretz R.C., and Wisniewski H.M. Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol. (Berl.) 78 (1989) 359-371
28. Losy J., Niezgoda A., and Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J. Neuroimmunol. 99 (1999) 169-172
29. Lovett-Racke A.E., and Racke M.K. Epstein-Barr virus and multiple sclerosis. Arch. Neurol. 63 (2006) 810-811
30. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000) 707-717
31. Lyck R., Reiss Y., Gerwin N., Greenwood J., Adamson P., and Engelhardt B. T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: The cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood 102 (2003) 3675-3683
32. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppacciaro A., Ruco L., Villa A., Simmons D., and Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142 (1998) 117-127
33. McMenamin P.G., Forrester J.V., Steptoe R.J., and Dua H.S. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium. Lab. Invest. 67 (1992) 42-55
34. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., O'Connor P.W., and International Natalizumab Multiple Sclerosis Trial Group. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348 (2003) 15-23
35. Minagar A., and Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9 (2003) 540-549
36. Minagar A., Jy W., Jimenez J.J., Sheremata W.A., Mauro L.M., Mao W.W., Horstman L.L., and Ahn Y.S. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56 (2001) 1319-1324
37. Minagar A., Ostanin D., Long A.C., Jennings M., Kelley R.E., Sasaki M., and Alexander J.S. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells. Mult. Scler. 9 3 (2003) 235-238
38. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
39. Oshima T., Pavlick K.P., Laroux F.S., Verma S.K., Jordan P., Grisham M.B., Williams L., and Alexander J.S. Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. Am. J. Physiol. Cell Physiol. 281 4 (2001) C1096-C1105
40. Osmers I., Bullard D.C., and Barnum S.R. PSGL-1 is not required for development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 166 (2005) 193-196
41. Plumb J., McQuaid S., Mirakhur M., and Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 12 (2002) 154-169
42. Qing Z., Sandor M., Radvany Z., Sewell D., Falus A., Potthoff D., Muller W.A., and Fabry Z. Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J. Neuropathol. Exp. Neurol. 60 (2001) 798-807
43. Raine C.S., Cannella B., Duijvestijn A.M., and Cross A.H. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63 (1990) 476-489
44. Sasaki M., Elrod J.W., Jordan P., Itoh M., Joh T., Minagar A., and Alexander J.S. CYP450 dietary inhibitors attenuate TNF-alpha-stimulated endothelial molecule expression and leukocyte adhesion. Am. J. Physiol. Cell Physiol. 286 (2004) 931-939
45. Sasaki M., Jordan P., Welbourne T., Minagar A., Joh T., Itoh M., Elrod J.W., and Alexander J.S. Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha. BMC Physiol. 5 1 (2005) 3
46. Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., and Muller W.A. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3 (2002) 143-150
47. Seguin R., Biernacki K., Rotondo R.L., Prat A., and Antel J.P. Regulation and functional effects of monocyte migration across human brain-derived endothelial cells. J. Neuropathol. Exp. Neurol. 62 (2003) 412-419
48. Sheremata W.A., Jy W., Delgado S., Minagar A., McLarty J., and Ahn Y. Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31 + EMP) in multiple sclerosis. J. Neuroinflammation 3 (2006) 23
49. Sikorski E.E., Hallmann R., Berg E.L., and Butcher E.C. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 151 10 (1993) 5239-5250
50. Steffen B.J., Butcher E.C., and Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145 (1994) 189-201
51. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 (2006) 12-21
52. Wekerle H., Engelhardt B., Risau W., and Meyermann R. Interaction of T lymphocytes with cerebral endothelial cells in vitro. Brain. Pathol. 1 (1991) 107-114
53. Wolburg H., Wolburg-Buchholz K., and Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol. (Berl.) 109 (2005) 181-190